AI-driven classification and distinction of indoleamine and tryptophan 2,3-dioxygenase inhibitors by analysis of molecular electrostatic maps
Journal of Pharmaceutical Analysis · 2026-11 · 16 (11) · 101675
DOI: 10.1016/j.jpha.2026.101675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Hamid Irannejad und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Irannejad, H., & Foroumadi, A. (2026). AI-driven classification and distinction of indoleamine and tryptophan 2,3-dioxygenase inhibitors by analysis of molecular electrostatic maps. Journal of Pharmaceutical Analysis, 16(11), 101675. https://doi.org/10.1016/j.jpha.2026.101675
Vancouver
Irannejad H, Foroumadi A. AI-driven classification and distinction of indoleamine and tryptophan 2,3-dioxygenase inhibitors by analysis of molecular electrostatic maps. Journal of Pharmaceutical Analysis. 2026;16(11):101675. doi:10.1016/j.jpha.2026.101675
BibTeX
@article{Irannejad2026,
author = {Irannejad, Hamid and Foroumadi, Alireza},
title = {AI-driven classification and distinction of indoleamine and tryptophan 2,3-dioxygenase inhibitors by analysis of molecular electrostatic maps},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
volume = {16},
number = {11},
pages = {101675},
doi = {10.1016/j.jpha.2026.101675}
}
EUVIMED